Catalog No.
RHC40105
Species reactivity
Human
Host species
Mouse
Isotype
IgG1
Clonality
Monoclonal
Tested applications
ELISA: 1:10000, FCM: 1:200-1:400, IHC: 1:200-1:1000
Target
HLBP14, Lactose-binding lectin 1, LGALS1, HBL, HPL, Beta-galactoside-binding lectin L-14-I, Gal-1, Lectin galactoside-binding soluble 1, Putative MAPK-activating protein PM12, S-Lac lectin 1, Galaptin, Galectin-1, 14 kDa laminin-binding protein, 14 kDa lectin
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P09382
Applications
ELISA, FCM, IHC
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% Sodium Azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
R3B59
New insight for ulcerative colitis diagnosis via serum netrin-1 and galectin-1 biomarkers., PMID:40518925
The Immunomodulatory Role of Galectin-1 in the Tumour Microenvironment and Strategies for Therapeutic Applications., PMID:40507367
Glycosylation-driven programs coordinate immunoregulatory and pro-angiogenic functions of myeloid-derived suppressor cells., PMID:40381622
Nuclear Galectin-1 promotes KRAS-dependent activation of pancreatic cancer stellate cells., PMID:40172967
Galectin-1-Induced Tumor Associated Macrophages Repress Antitumor Immunity in Hepatocellular Carcinoma Through Recruitment of Tregs., PMID:39853961
Impact of galectin-1's redox state on its lectin activity and monomer-dimer equilibrium. Focusing on oxidized Gal-1., PMID:39755294
Ganoderic acid T, a Ganoderma triterpenoid, modulates the tumor microenvironment and enhances the chemotherapy and immunotherapy efficacy through downregulating galectin-1 levels., PMID:39142358
Pre-B cell receptor acts as a selectivity switch for galectin-1 at the pre-B cell surface., PMID:39058594
Circulating immune-related proteins associated with immune checkpoint inhibitor efficacy in patients with pancreatic ductal adenocarcinoma., PMID:38838501
Noninvasively Deciphering the Immunosuppressive Tumor Microenvironment Using Galectin-1 PET to Inform Immunotherapy Responses., PMID:38514084
Mesenchymal stromal cells plus basiliximab improve the response of steroid-refractory acute graft-versus-host disease as a second-line therapy: a multicentre, randomized, controlled trial., PMID:38413930
Enzymatically-derived oligo-carrageenans interact with α-Gal antibodies and Galectin-3., PMID:37985065
Generation and characterization of a monoclonal antibody that binds to Galectin-1., PMID:37209931
Targeting galectin-driven regulatory circuits in cancer and fibrosis., PMID:36759557
Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology., PMID:36634146
Decoding Strategies to Evade Immunoregulators Galectin-1, -3, and -9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy., PMID:36555198
Plasma galectins and metabolites in advanced head and neck carcinomas: evidence of distinct immune characteristics linked to hypopharyngeal tumors., PMID:36545254
Prevalence of high affinity naturally occurring IgG2 antibodies against human chorionic gonadotropin and its subunits in patients with ovarian cyst., PMID:36088866
Regulatory T cells, damage-associated molecular patterns, and myeloid-derived suppressor cells in bronchoalveolar lavage fluid interlinked with chronic obstructive pulmonary disease severity: An observational study., PMID:35687771
Soluble CD146 is increased in preeclampsia and interacts with galectin-1 to regulate trophoblast migration through VEGFR2 receptor., PMID:35559998
Role of MDM2, CDK4, BCL2, Parafibromin and Galectin 1 in Differentiating Osteosarcoma from its Benign Fibro-osseous Lesions., PMID:35220546
Vaccination against galectin-1 promotes cytotoxic T-cell infiltration in melanoma and reduces tumor burden., PMID:35018481
Dual electrochemical sensing of spiked virus and SARS-CoV-2 using natural bed-receptor (MV-gal1)., PMID:34836981
Serum galectin-9 could be a potential biomarker in assessing the disease activity of antineutrophil cytoplasmic antibody-associated vasculitis., PMID:34001301
A minigene DNA vaccine encoding peptide epitopes derived from Galectin-1 has protective antitumoral effects in a model of neuroblastoma., PMID:33848518
Characterization of a neutralizing anti-human galectin-1 monoclonal antibody with angioregulatory and immunomodulatory activities., PMID:33006019
Pancreatic Cancer detection via Galectin-1-targeted Thermoacoustic Imaging: validation in an in vivo heterozygosity model., PMID:32802185
Increased serum levels of galectin-9 in patients with chikungunya fever., PMID:32565125
Galectin-1 expression in oral squamous cell carcinoma: An immunohistochemical study., PMID:32508476
Galectin-1 and Galectin-3 Expression in Lesional Skin of Patients With Systemic Sclerosis-Association With Disease Severity., PMID:32501939
Prompting Fab Yeast Surface Display Efficiency by ER Retention and Molecular Chaperon Co-expression., PMID:32039168
No Bull: A Case of Alpha-Gal Syndrome Associated With Buffalo Meat Sensitivity., PMID:31840005
Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance., PMID:31710313
Anti-inflammatory Property of Galectin-1 in a Murine Model of Allergic Airway Inflammation., PMID:31214624
The opposite roles of PAS-5 and Galectin-1 in immune response during the early infection of Angiostrongylus cantonensis., PMID:29843794
Immunoglobulins from sera of APS patients bind HTR-8/SVneo trophoblast cell line and reduce additional mediators of cell invasion., PMID:29102762
Toward a new and noninvasive diagnostic method of papillary thyroid cancer by using peptide vectorized contrast agents targeted to galectin-1., PMID:28986753
Anti-inflammatory effect of galectin-1 in a murine model of atopic dermatitis., PMID:28664215
Differential protein expression in chicken macrophages and heterophils in vivo following infection with Salmonella Enteritidis., PMID:28623956
Combined Anti-VEGF and Anti-CTLA-4 Therapy Elicits Humoral Immunity to Galectin-1 Which Is Associated with Favorable Clinical Outcomes., PMID:28473314
Galectin-1 expression is associated with tumour immunity and prognosis in gingival squamous cell carcinoma., PMID:28108653
Galectin-1 inhibits oral-intestinal allergy syndrome., PMID:28086216
HyCCAPP as a tool to characterize promoter DNA-protein interactions in Saccharomyces cerevisiae., PMID:27184763
Placental Expression Patterns of Galectin-1, Galectin-2, Galectin-3 and Galectin-13 in Cases of Intrauterine Growth Restriction (IUGR)., PMID:27070577
Galectin-1 is a useful marker for detecting neoplastic squamous cells in oral cytology smears., PMID:26980012
Comparative analyses on expression of galectins1-4, 7-10 and 12 in first trimester placenta, decidua and isolated trophoblast cells in vitro., PMID:26901464
Galectin-1 drives lymphoma CD20 immunotherapy resistance: validation of a preclinical system to identify resistance mechanisms., PMID:26888257
Immunosensor for the ultrasensitive and quantitative detection of bladder cancer in point of care testing., PMID:26777732
Isolation and Flow Cytometric Analysis of Glioma-infiltrating Peripheral Blood Mononuclear Cells., PMID:26650233
Gal-1 silenced trophoblast tumor cells (BeWo) show decreased syncytium formation and different miRNA production compared to non-target silenced BeWo cells., PMID:26418280
For research use only. Not for human or drug use.
